Pharmacokinetics And Relative Bioavailability Of Absorbed Testosterone After Administration Of A 1.62% Testosterone Gel To Different Application Sites In Men With Hypogonadism

生物利用度 睾酮(贴片) 医学 药代动力学 交叉研究 内科学 肩膀 二氢睾酮 内分泌学 曲线下面积 腹部 雄激素 药理学 激素 外科 替代医学 病理 安慰剂
作者
Jodi L. Miller,Margaret Britto,Suzanna Fitzpatrick,Cecilia McWhirter,Samuel A Testino,John J. Brennan,Troy L. ZumBrunnen
出处
期刊:Endocrine Practice [Elsevier BV]
卷期号:17 (4): 574-583 被引量:23
标识
DOI:10.4158/ep10192.or
摘要

ABSTRACT

Objective

To determine the pharmacokinetics, bioavailability, and safety of a new formulation (1.62%) of testosterone gel that produces eugonadal serum testosterone levels with use of a lower amount of gel than the currently available 1% gels.

Methods

In an open-label, randomized, 3-way crossover study, 36 male patients with hypogonadism applied 5 g of 1.62% testosterone gel (81 mg of testosterone) once daily to the abdomen, to the upper arms/shoulders, or alternating between both sites per an established schedule for 7 days. Serum levels of testosterone, dihydrotestosterone, and estradiol were measured and used to compare the pharmacokinetics and bioavailability of the 3 treatments.

Results

Each application method produced average serum testosterone concentrations within the eugonadal range (300 to 1,000 ng/dL), and steady-state testosterone concentrations were achieved after 2 days of gel application to either the abdomen or the upper arms/shoulders. When testosterone gel was applied to the abdomen, approximately 30% to 40% lower bioavailability (based on area under the serum concentration-time curve from 0 to 24 hours) was observed in comparison with application to the upper arms/shoulders. The 1.62% testosterone gel was found to be safe and well tolerated in men with hypogonadism.

Conclusion

Although lower testosterone bioavailability was observed after abdominal application of 1.62% testosterone gel in comparison with application to the upper arms/shoulders, application to either site yielded eugonadal levels of serum testosterone. (Endocr Pract. 2011;17:574-583)

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
畅畅完成签到 ,获得积分10
刚刚
ChatGPT发布了新的文献求助10
1秒前
李健的小迷弟应助la采纳,获得10
1秒前
ZYN完成签到 ,获得积分10
2秒前
Mason完成签到,获得积分10
3秒前
yizhe发布了新的文献求助10
3秒前
JamesPei应助zzzz采纳,获得10
4秒前
英俊的铭应助aa采纳,获得30
4秒前
xiaohuhuan完成签到,获得积分10
4秒前
bulingbuling完成签到 ,获得积分10
5秒前
一颗小纽扣完成签到,获得积分10
6秒前
席涑完成签到,获得积分10
7秒前
CipherSage应助拼搏的婷冉采纳,获得10
7秒前
luoluo完成签到 ,获得积分10
8秒前
8秒前
醋炒栗子仁完成签到,获得积分10
8秒前
墨尔根戴青完成签到,获得积分10
9秒前
瑾瑜完成签到,获得积分10
10秒前
文小杰完成签到,获得积分10
10秒前
山月完成签到,获得积分10
11秒前
CodeCraft应助研友_LOK59L采纳,获得10
11秒前
11秒前
12秒前
欣慰妙海完成签到 ,获得积分20
12秒前
CodeCraft应助zhaopeipei采纳,获得10
12秒前
LIUYONG发布了新的文献求助10
13秒前
lin发布了新的文献求助10
15秒前
16秒前
九湖夷上完成签到 ,获得积分10
16秒前
噼里啪啦完成签到 ,获得积分10
17秒前
大个应助hahaha123213123采纳,获得30
17秒前
17秒前
惊天大幂幂完成签到,获得积分10
17秒前
英姑应助Fang Xianxin采纳,获得10
18秒前
宋老师发布了新的文献求助30
18秒前
王洋完成签到,获得积分10
19秒前
lw777完成签到,获得积分20
19秒前
慢慢完成签到,获得积分10
19秒前
20秒前
靖123456发布了新的文献求助10
20秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029